Published in J Clin Invest on July 01, 1961
Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest (1970) 4.74
IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A (1963) 3.31
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest (2012) 2.98
The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest (1967) 2.53
Antibody to intrinsic factor in serum from patients with pernicious anemia. J Clin Invest (1962) 2.50
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest (1968) 2.46
The effects of total starvation upon the levels of circulating glucagon and insulin in man. J Clin Invest (1963) 2.43
Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J Clin Invest (1962) 2.40
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J Clin Invest (1968) 1.71
An enteroglucagon tumour. Gut (1972) 1.69
Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. Proc Natl Acad Sci U S A (1966) 1.42
Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women. J Clin Invest (1968) 1.37
Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg (1978) 1.29
Fasting: the history, pathophysiology and complications. West J Med (1982) 1.09
A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest (1995) 1.05
Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest (1997) 0.98
Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog. J Clin Invest (1981) 0.94
Hormonal control of pancreatic endocrine and exocrine secretion. Gut (1972) 0.90
Unraveling oxyntomodulin, GLP1's enigmatic brother. J Endocrinol (2012) 0.88
A new bioassay for glucagon. Br J Pharmacol (1978) 0.86
The half-life of exogenous gastrin in the circulation. J Physiol (1970) 0.85
Clearance of immunoreactive somatostatin by perfused rat liver. J Clin Invest (1981) 0.84
The experimental generation of antibodies to alpha-melanocyte stimulating hormone and adrenocorticotropic hormone. J Clin Invest (1965) 0.80
Biliary response to glucagon in humans. Ann Surg (1991) 0.80
Gene expression of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in a poorly ketogenic mammal: effect of starvation during the neonatal period of the piglet. Biochem J (1997) 0.78
Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc (1982) 0.78
Enhancement of insulin action after oral glucose ingestion. J Clin Invest (1986) 0.76
Granulolysis in a cells of endocrine pancreas in spontaneous and experimental diabetes in animals. J Cell Biol (1968) 0.75
RHABDOMYOSARCOMA OF THE BUTTOCK PRODUCING HYPOGLYCEMIA. Ann Surg (1965) 0.75
An AlphaScreen Assay for the Discovery of Synthetic Chemical Inhibitors of Glucagon Production. J Biomol Screen (2015) 0.75
High circulating concentrations of glucagon in non-anaemic uraemic patients. Br Med J (1978) 0.75
Immunoassay of endogenous plasma insulin in man. J Clin Invest (1960) 25.67
Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest (1956) 8.87
Glucagon antibodies and their use for immunoassay for glucagon. Proc Soc Exp Biol Med (1960) 7.82
The zone of localization of antibodies. V. An attempt to saturate antibody-binding sites in mouse kidney. J Immunol (1950) 4.73
Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest (1959) 3.72
An immunochemical assay of total extractable insulin in man. J Clin Invest (1960) 3.42
The hyperglycaemic action of blood from animals treated with growth hormone. Nature (1951) 2.28
Evidence for the insulin-directed specificity of rabbit anti-insulin serum. J Clin Invest (1956) 2.25
Nonprecipitating insulin antibodies. J Clin Invest (1958) 2.00
Apparent inhibition of liver insulinase activity by serum and serum fractions containing insulin-binding antibody. J Clin Invest (1957) 1.64
Purification and crystallization of glucagon. J Biol Chem (1955) 1.50
In vivo and in vitro metabolism of insulin-I 131 and glucagon-I 131 in normal and cortisone-treated rabbits. J Lab Clin Med (1957) 1.40
Isotopic tracers in the study of diabetes. Adv Biol Med Phys (1958) 1.25
Some aspects of the glucagon problem. Am J Med (1959) 1.16
Hypotensive reaction following the use of glucagon. AMA Arch Intern Med (1957) 1.05
The destruction of glucagon, adrenocorticotropin and somatotropin by human blood plasma. J Clin Invest (1959) 0.95
Presence of a glucagon-like material in blood of man and dog. J Biol Chem (1958) 0.89
Assay for glucagon in rabbit plasma. Metabolism (1958) 0.89
Glucagon antibodies and their use for immunoassay for glucagon. Proc Soc Exp Biol Med (1960) 7.82
The effects of total starvation upon the levels of circulating glucagon and insulin in man. J Clin Invest (1963) 2.43
The relationship between the mechanism of action of the sulfonylureas and the secretion of insulin into the portal circulation. Ann N Y Acad Sci (1959) 2.41
Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J Clin Invest (1962) 2.40
The physiological significance of the secretion of endogenous insulin into the portal circulation. III. Evidence for a direct immediate effect of insulin on the balance of glucose across the liver. J Clin Invest (1960) 2.02
THE HYPOGLYCEMIC ACTION OF KETONES. II. EVIDENCE FOR A STIMULATORY FEEDBACK OF KETONES ON THE PANCREATIC BETA CELLS. J Clin Invest (1964) 1.86
The standard two-hour oral glucose tolerance test in the diagnosis of diabetes mellitus in subjects without fasting hyperglycemia. Ann Intern Med (1957) 1.60
A new diagnostic procedure for mild diabetes mellitus; evaluation of an intravenous tolbutamide response test. Diabetes (1959) 1.44
Comparison of response to intravenously administered sodium tolbutamide in milk diabetic and non-diabetic subjects. J Clin Invest (1958) 1.25
IDENTIFICATION OF INSULIN AND GLUGACON IN A BRONCHOGENIC METASTASIS. J Clin Endocrinol Metab (1964) 1.24
THE ACUTE EFFECT OF HYDROCORTISONE ON HEPATIC GLUCOSE OUTPUT AND PERIPHERAL GLUCOSE UTILIZATION. J Clin Invest (1964) 1.18
HYPOGLYCEMIC ACTION OF KETONES. I. EFFECTS OF KETONES ON HEPATIC GLUCOSE OUTPUT AND PERIPHERAL GLUCOSE UTILIZATION. J Lab Clin Med (1964) 1.15
The tagging of leukemic leukocytes with radioactive chromium and measurement of the in vivo cell survival. J Lab Clin Med (1955) 1.12
Ammonia excretion and renal enzymatic adaptation in human subjects, as disclosed by administration of precursor amino acids. J Clin Invest (1958) 1.12
Tolbutamide-phenformin in ketoacidosis-resistant patients. JAMA (1960) 1.11
Effect of phenoformin on peripheral glucose utilization in human diabetic and nondiabetic subjects. Diabetes (1960) 1.09
A study of arsenic in regular-sized unfiltered and filtered cigarettes. Cancer (1959) 1.07
The physiological significance of the secretion of endogenous insulin into the portal circulation. IV. Hepatic uptake of glucose during glucose infusion in non-diabetic dogs. J Clin Invest (1961) 1.04
STUDIES OF THE PHYSIOLOGIC ROLE OF GLUCAGON. Diabetes (1965) 1.03
Evidence for a direct effect of insulin on hepatic glucose output. Metabolism (1959) 1.02
Scleroderma. Am J Med (1950) 0.97
THE ISOLATION AND CHARACTERIZATION OF PORCINE GASTRIN. J Biol Chem (1965) 0.92
Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. Diabetes (1963) 0.91
The measurement of the survival of human erythrocytes by in vivo tagging with Cr51. Blood (1955) 0.88
The direct Coombs test and reticulocytes. Br J Haematol (1963) 0.87
HIGH GROWTH-HORMONE LEVELS IN DIABETIC KETOACIDOSIS: A POSSIBLE CAUSE OF INSULIN RESISTANCE. JAMA (1965) 0.85
The physiologic significance of secretion of insulin into portal circulation: II. Effect of rate of administration of glucagon-free insulin on magnitude of peripheral and hepatic actions. Metabolism (1960) 0.84
Comparison of the effects of insulin and orinase (tolbutamide) on peripheral glucose utilization in the dog. Metabolism (1958) 0.84
Comparison of the anterior pituitary-adrenal cortical stimulating effect of U.S.P. epinephrine, synthetic L-epinephrine, and nor-epinephrine. J Clin Invest (1950) 0.84
The direct Coombs test in lead poisoning. Blood (1956) 0.82
THE EFFECTS OF COCL-2 ON GLUCAGON LEVELS IN PLASMA AND PANCREAS OF THE RAT. Metabolism (1964) 0.81
The survival of human erythrocytes estimated by means of cells tagged with radioactive chromium; a study of the normal state. J Lab Clin Med (1954) 0.79
Relative effectiveness of newer oral agents in the regulation of diabetic patients imperfectly controlled by tolbutamide studied within the framework of a tentative subclassification of the disease. Ann N Y Acad Sci (1959) 0.77
An electrical analogue for analysis of tracer distribution kinetics in biological systems. Radiat Res (1957) 0.76
The cigarette smoke-arsenic-cancer of the lung problem. Acta Unio Int Contra Cancrum (1959) 0.76
The effect of cigarette smoke on the respiratory system of the rabbit; a preliminary report. Cancer (1958) 0.75
The apparent superiority of tolbutamide over insulin in the regulation of selected clinic patients. South Med J (1958) 0.75
SEPARATION OF HUMAN INSULIN, GLUCAGON AND OTHER PANCREATIC PROTEINS. Diabetes (1965) 0.75
Current status of aryl sulfonylureas in treatment of diabetes mellitus. J Am Med Assoc (1956) 0.75
The intravenous tolbutamide response test in the diagnosis of mild diabetes. Ann N Y Acad Sci (1959) 0.75
The proper choice of oral antihyperglycemic therpy in diabetes mellitus. Postgrad Med (1961) 0.75
Medical emergencies in diabetes. Med Clin North Am (1962) 0.75
Homologous serum hepatitis as a complication of transfusion. N Y State J Med (1955) 0.75